• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    12/7/23 1:13:56 PM ET
    $AAMC
    $ABBV
    $AGX
    $AI
    Real Estate
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAMC alert in real time by email

    Shares of Methode Electronics, Inc (NYSE:MEI) fell sharply during Thursday’s session following weak quarterly earnings.

    Methode Electronics posted adjusted earnings of 6 cents per share, missing market estimates of 12 cents per share. The company’s quarterly sales came in at $288.00 million versus expectations of $292.82 million, according to Benzinga Pro.

    Methode Electronics shares fell 14.2% to $20.92 on Thursday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Save Foods, Inc. (NASDAQ:SVFD) shares climbed 186.7% to $6.16 after the company highlighted targeting of US carbon credit market following acquisition of majority ownership in newly- formed Nitrousink Ltd.
    • Cyngn Inc. (NASDAQ:CYN) gained 90.4% to $0.4643 after the company announced the issuance of a new patent, US-11,837,089-B2, for the autonomous vehicle (AV) and driving solutions.
    • Barnes & Noble Education, Inc. (NYSE:BNED) shares climbed 31.9% to $1.3850 following upbeat quarterly earnings.
    • Hempacco Co., Inc. (NASDAQ:HPCO) shares climbed 28.8% to $0.4331 after the company announced it entered into an exclusive Master Distribution Agreement with CBDAY Global. Under the agreement, CBDAY will exclusively sell Hempacco's line of hemp and CBD products in India and Thailand.
    • MicroAlgo Inc. (NASDAQ:MLGO) shares gained 26% to $12.07. MicroAlgo shares jumped over 295% on Wednesday after the company announced it plans to establish a postgraduate training practice base.
    • Kewaunee Scientific Corporation (NASDAQ:KEQU) climbed 25.5% to $22.53 following second-quarter earnings.
    • Inogen, Inc. (NASDAQ:INGN) climbed 23.3% to $6.15.
    • Satellogic Inc. (NASDAQ:SATL) rose 22% to $1.9584. Uzma and Satellogic signed a multi-million dollar +3-year agreement to advance geospatial capabilities in Southeast Asia.
    • Fitell Corporation (NASDAQ:FTEL) gained 19.7% to $1.70.
    • Altisource Asset Management Corporation(NYSE:AAMC) gained 19.3% to $4.0213. Altisource Asset Management reported key ruling in Blackrock and PIMCO litigation.
    • Semtech Corporation (NASDAQ:SMTC) climbed 18.5% to $19.80 after the company reported third-quarter financial results and issued guidance.
    • Altimmune, Inc. (NASDAQ:ALT) gained 18.3% to $8.14.
    • Solid Biosciences Inc. (NASDAQ:SLDB) gained 17.6% to $4.0250. Solid Biosciences received FDA fast track designation for its SGT-003 duchenne muscular dystrophy gene therapy candidate.
    • JetBlue Airways Corporation (NASDAQ:JBLU) climbed 15.8% to $5.48 after the company said that demand for travel remains healthy, with close-in bookings outperforming expectations for both holiday peak and non-holiday travel periods since late October.
    • Siyata Mobile Inc. (NASDAQ:SYTA) rose 15.2% to $3.8001 after announcing $900,000 follow-on orders.
    • Verint Systems Inc. (NASDAQ:VRNT) gained 14% to $27.40 after the company reported better-than-expected third-quarter financial results and issued guidance.
    • Lilium N.V. (NASDAQ:LILM) gained 14% to $1.2650 after the company announced it signed a Memorandum of Understanding with Lufthansa Group for a strategic partnership.
    • AerSale Corporation (NASDAQ:ASLE) shares surged 13.4% to $16.16 after the company announced the FAA has issued the company a Supplemental Type Certificate for AerAware, its Enhanced Flight Vision System for the Boeing B737NG product line.
    • Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) gained 12.2% to $41.44 after AbbVie Inc. (NYSE:ABBV) announced it will acquire the company for a total equity value of approximately $8.7 billion.
    • IES Holdings, Inc. (NASDAQ:IESC) gained 11.8% to $79.68 following quarterly results.
    • Couchbase, Inc. (NASDAQ:BASE) rose 5.7% to $21.07 as the company reported upbeat results for its third quarter and issued strong revenue outlook for FY24.
    • Alphabet Inc. (NASDAQ:GOOGL) gained 5.1% to $136.62. Google made a significant announcement, launching Gemini AI, its most powerful AI model to date.

    Losers

    • Troika Media Group, Inc. (NASDAQ:TRKA) shares fell 74.8% to $0.4812 after the company announced it filed for Chapter 11.
    • Phio Pharmaceuticals Corp. (NASDAQ:PHIO) shares dipped 40% to $0.9462 as the company announced exercise of warrants for $2.8 million gross proceeds.
    • Bit Brother Limited (NASDAQ:BETS) fell 38.8% to $0.0214. Bit Brother recently announced the pricing of a $12 million registered direct offering.
    • FLJ Group Limited (NASDAQ:FLJ) fell 36% to $2.91.
    • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) shares tumbled 35.4% to $1.3789 after the company priced its $5 million public offering.
    • Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) fell 32.8% to $1.25 as the company announced pricing of $4.5 million registered direct offering.
    • Red Cat Holdings, Inc. (NASDAQ:RCAT) shares fell 30.5% to $0.5280. Red Cat priced public offering of 16 million common shares at $0.50 per share for gross proceeds of $8 million.
    • Sprinklr, Inc. (NYSE:CXM) shares fell 29.4% to $11.76 following weak earnings for the third quarter.
    • Wave Life Sciences Ltd. (NASDAQ:WVE) shares fell 29.1% to $4.87 after the company priced its $100 million public offering of ordinary shares.
    • Nogin, Inc. (NASDAQ:NOGN) fell 26.3% to $0.1334 after the company entered Chapter 11 bankruptcy proceedings in combination with a stalking horse bid and Debtor in Possession financing provided by B. Riley Financial, Inc.
    • enGene Holdings Inc. (NASDAQ:ENGN) declined 23.8% to $7.87.
    • Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) fell 21.4% to $4.18. Sportsman's Warehouse said it sees fourth-quarter loss of 35 cents to 25 cents per share.
    • Phunware, Inc. (NASDAQ:PHUN) fell 19% to $0.1030 as the company reported pricing of $2.8 million public offering.
    • Nikola Corporation (NASDAQ:NKLA) fell 18.1% to $0.8047 after the company announced proposed offerings of common stock and convertible senior notes.
    • BAIYU Holdings, Inc. (NASDAQ:BYU) shares fell 17.7% to $1.49.
    • Vivid Seats Inc. (NASDAQ:SEAT) declined 15.6% to $6.87. Vivid Seats announced secondary offering of 18.5 million class A common stock.
    • Argan, Inc. (NYSE:AGX) fell 13.1% to $41.50 following downbeat earnings.
    • Liquidity Services, Inc. (NASDAQ:LQDT) dipped 12.8% to $17.36 following weak sales.
    • The Duckhorn Portfolio, Inc. (NYSE:NAPA) fell 10.7% to $9.11 following downbeat quarterly results.
    • C3.ai, Inc. (NYSE:AI) shares fell 9.8% to $26.30 after the company reported mixed second-quarter financial results and issued guidance.
    • Chewy, Inc. (NYSE:CHWY) fell 6% to $18.18 after the company reported mixed third-quarter financial results and cut FY23 net sales guidance.
    • Ollie's Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) declined 5.5% to $72.09.
    • Greif, Inc. (NYSE:GEF) declined 5.5% to $65.83 following weak sales.
    • Veeva Systems Inc. (NYSE:VEEV) shares fell 4.1% to $171.20 after the company reported third-quarter financial results and issued guidance.

     

    Now Read This: 'I Like It Very Much': Jim Cramer Bullish On This Financial Stock Up 75% YTD

    Get the next $AAMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAMC
    $ABBV
    $AGX
    $AI

    CompanyDatePrice TargetRatingAnalyst
    AbbVie Inc.
    $ABBV
    4/21/2026$262.00Buy
    Canaccord Genuity
    Alphabet Inc.
    $GOOGL
    4/20/2026$370.00 → $380.00Overweight
    KeyBanc Capital Markets
    JetBlue Airways Corporation
    $JBLU
    4/16/2026$8.00Neutral → Buy
    Seaport Research Partners
    Alphabet Inc.
    $GOOGL
    4/14/2026$390.00 → $405.00Buy
    Citigroup
    enGene Therapeutics Inc.
    $ENGN
    4/13/2026$21.50Buy
    WBB Securities
    Veeva Systems Inc.
    $VEEV
    4/10/2026$176.00Buy → Neutral
    Citigroup
    Alphabet Inc.
    $GOOGL
    4/10/2026$410.00 → $420.00Outperform
    Mizuho
    Alphabet Inc.
    $GOOGL
    4/10/2026$390.00 → $360.00Outperform
    Wolfe Research
    More analyst ratings

    $AAMC
    $ABBV
    $AGX
    $AI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President St George Martin J converted options into 46,882 shares and covered exercise/tax liability with 23,934 shares, increasing direct ownership by 23% to 120,857 units (SEC Form 4) (withholding tax)

    4 - JETBLUE AIRWAYS CORP (0001158463) (Issuer)

    4/23/26 5:13:58 PM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form 4 filed by General Counsel Corp Sec Mccarthy Eileen P

    4 - JETBLUE AIRWAYS CORP (0001158463) (Issuer)

    4/23/26 5:13:14 PM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form 4 filed by Chief Financial Officer Hurley Ursula L

    4 - JETBLUE AIRWAYS CORP (0001158463) (Issuer)

    4/23/26 5:13:07 PM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    $AAMC
    $ABBV
    $AGX
    $AI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on AbbVie with a new price target

    Canaccord Genuity initiated coverage of AbbVie with a rating of Buy and set a new price target of $262.00

    4/21/26 7:30:27 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    KeyBanc Capital Markets reiterated coverage on Alphabet A with a new price target

    KeyBanc Capital Markets reiterated coverage of Alphabet A with a rating of Overweight and set a new price target of $380.00 from $370.00 previously

    4/20/26 9:39:07 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    JetBlue Airways upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded JetBlue Airways from Neutral to Buy and set a new price target of $8.00

    4/16/26 8:06:55 AM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    $AAMC
    $ABBV
    $AGX
    $AI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fedder Judith Ann bought $6,464 worth of shares (1,000 units at $6.46), increasing direct ownership by 2% to 62,175 units (SEC Form 4)

    4 - AerSale Corp (0001754170) (Issuer)

    3/16/26 6:55:45 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    Chief Financial Officer Weaver Gregory L bought $17,700 worth of shares (5,000 units at $3.54), increasing direct ownership by 22% to 28,078 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:05:04 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Durso Jerome Benedict bought $70,790 worth of shares (20,000 units at $3.54), increasing direct ownership by 160% to 32,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:00:05 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $ABBV
    $AGX
    $AI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AerSale® Announces Date for First Quarter 2026 Earnings Release Conference Call

    MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- AerSale Corporation (NASDAQ:ASLE) (the "Company"), announced today that it will release its earnings results for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, after the market closes. The Company will host a conference call on the same day at 4:30 pm Eastern Time to discuss the results. A live audio webcast of the call will be available to the public on a listen‑only basis at https://ir.aersale.com/news-events/events. An archived replay of the webcast will also be available on the Investors portion of the AerSale website at https://ir.aersale.com for one year. About AerSale AerSale is a global provider of integrated aviation

    4/23/26 4:30:00 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.

    U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for trenibotulinumtoxinE (TrenibotE) related to manufacturing processes; no additional clinical studies are requested As the leader in neurotoxin development and manufacturing, AbbVie is well positioned to address all comments in a timely mannerNORTH CHICAGO, Ill., April 23, 2026 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Biologics License Application (BLA) for trenibotulinumtoxinE (TrenibotE), a first-in-class botulinum neurotoxin serotype E with a rapid onset of effect and short duration.   In

    4/23/26 4:05:00 PM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Five Under-the-Radar Stocks With Catalysts Already in Motion — Across AI Defense, Space, Longevity, Gold, and Post-Quantum Security

    Issued on behalf of VisionWave Holdings, Inc., Starfighters Space, Inc., Avaí Bio, Inc., Lake Victoria Gold Ltd., and QSE – Quantum Secure Encryption Corp. Five small-cap companies operating in very different sectors share one trait that tends to precede re-ratings: near-term catalysts that have already started to land. Companies Mentioned in this Article: VisionWave Holdings, Inc. (NASDAQ:VWAV), Starfighters Space, Inc. (NYSE:FJET), Avaí Bio, Inc. (OTCQB:AVAI), Lake Victoria Gold Ltd. (TSXV:LVG) (OTCQB:LVGLF) (FSE: E1K), QSE – Quantum Secure Encryption Corp. (CSE:QSE) (OTCQB:QSEGF) (FSE: VN80) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) closed a $20 million senior loan in late Febr

    4/23/26 12:00:00 PM ET
    $FJET
    $FRSX
    $VWAV
    Air Freight/Delivery Services
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    $AAMC
    $ABBV
    $AGX
    $AI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VYALEV issued to ABBVIE INC

    Submission status for ABBVIE INC's drug VYALEV (ORIG-1) with active ingredient FOSCARBIDOPA AND FOSLEVODOPA has changed to 'Approval' on 10/16/2024. Application Category: NDA, Application Number: 216962, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    10/18/24 4:38:13 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYALEV issued to ABBVIE INC

    Submission status for ABBVIE INC's drug VYALEV (ORIG-1) with active ingredient FOSCARBIDOPA AND FOSLEVODOPA has changed to 'Approval' on 10/16/2024. Application Category: NDA, Application Number: 216962, Application Classification: Type 3 - New Dosage Form

    10/17/24 1:29:31 PM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SKYRIZI issued to ABBVIE INC

    Submission status for ABBVIE INC's drug SKYRIZI (SUPPL-7) with active ingredient RISANKIZUMAB-RZAA has changed to 'Approval' on 06/18/2024. Application Category: BLA, Application Number: 761262, Application Classification:

    6/21/24 4:38:17 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $ABBV
    $AGX
    $AI
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by JetBlue Airways Corporation

    SCHEDULE 13D/A - JETBLUE AIRWAYS CORP (0001158463) (Subject)

    4/23/26 4:55:25 PM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form DEF 14A filed by Satellogic Inc.

    DEF 14A - Satellogic Inc. (0001874315) (Filer)

    4/23/26 4:27:59 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form DEFA14A filed by Solid Biosciences Inc.

    DEFA14A - Solid Biosciences Inc. (0001707502) (Filer)

    4/23/26 4:07:44 PM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAMC
    $ABBV
    $AGX
    $AI
    Financials

    Live finance-specific insights

    View All

    AerSale® Announces Date for First Quarter 2026 Earnings Release Conference Call

    MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- AerSale Corporation (NASDAQ:ASLE) (the "Company"), announced today that it will release its earnings results for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, after the market closes. The Company will host a conference call on the same day at 4:30 pm Eastern Time to discuss the results. A live audio webcast of the call will be available to the public on a listen‑only basis at https://ir.aersale.com/news-events/events. An archived replay of the webcast will also be available on the Investors portion of the AerSale website at https://ir.aersale.com for one year. About AerSale AerSale is a global provider of integrated aviation

    4/23/26 4:30:00 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    Five Under-the-Radar Stocks With Catalysts Already in Motion — Across AI Defense, Space, Longevity, Gold, and Post-Quantum Security

    Issued on behalf of VisionWave Holdings, Inc., Starfighters Space, Inc., Avaí Bio, Inc., Lake Victoria Gold Ltd., and QSE – Quantum Secure Encryption Corp. Five small-cap companies operating in very different sectors share one trait that tends to precede re-ratings: near-term catalysts that have already started to land. Companies Mentioned in this Article: VisionWave Holdings, Inc. (NASDAQ:VWAV), Starfighters Space, Inc. (NYSE:FJET), Avaí Bio, Inc. (OTCQB:AVAI), Lake Victoria Gold Ltd. (TSXV:LVG) (OTCQB:LVGLF) (FSE: E1K), QSE – Quantum Secure Encryption Corp. (CSE:QSE) (OTCQB:QSEGF) (FSE: VN80) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) closed a $20 million senior loan in late Febr

    4/23/26 12:00:00 PM ET
    $FJET
    $FRSX
    $VWAV
    Air Freight/Delivery Services
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    Inogen to Report First Quarter 2026 Financial Results on May 7, 2026

    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET. Individuals interested in listening to the conference call may do so by dialing: U.S. domestic callers (877) 841-3961 Non-U.S. callers (201) 689-8589 Please reference Inogen to join the call. A live audio webcast and archived recording of the conference call will be available to all interested parties through the News / Events page on the Inogen I

    4/23/26 8:30:00 AM ET
    $INGN
    Industrial Specialties
    Health Care

    $AAMC
    $ABBV
    $AGX
    $AI
    Leadership Updates

    Live Leadership Updates

    View All

    As the Counter-Drone Era Goes Mainstream, This Nasdaq AI Defense Stock Just Landed a World Cup Deployment Order

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this commentary include: VisionWave Holdings, Inc. (NASDAQ:VWAV), Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), Red Cat Holdings, Inc. (NASDAQ:RCAT), Ondas Holdings Inc. (NASDAQ:ONDS), Unusual Machines, Inc. (NYSE:UMAC). Key Takeaways: The global counter-drone market has become one of the fastest-growing niches in defense, driven by the proliferation of cheap weaponized UAS across battlefields and public events.VisionWave Holdings (NASDAQ:VWAV) presented its three-pillar technology platform — VisionRF™, Stratum™, and qSpeed™ — to more than 580 investors at the 91st Emerging Growth Conference on April 2,

    4/16/26 9:00:00 AM ET
    $KTOS
    $ONDS
    $RCAT
    Military/Government/Technical
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Kewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group

    STATESVILLE, N.C., April 14, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced the appointment of Jorge Santos as VP – International Sales – Lab Products Group, further strengthening the Company's commercial leadership as it accelerates growth in key global markets. Santos joins Kewaunee as the newest member of the Company's leadership team and will report directly to President and Chief Executive Officer, Thomas D. Hull III. "Jorge's appointment marks a significant step forward in Kewaunee's growth strategy outside of the North American market,"

    4/14/26 4:02:00 PM ET
    $KEQU
    Medical Specialities
    Industrials

    Inogen Announces the Appointment of Vafa Jamali to Board of Directors

    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Vafa Jamali as an independent director to the Inogen Board of Directors (the "Board"), effective on the date of the Company's 2026 Annual Meeting, or June 15th if earlier. Mr. Jamali is a long-time medical device executive who will bring added depth and expertise to the Board. During his tenure as the Chief Executive Officer of ZimVie, he led the company's Nasdaq listing following the spin-out from Zimmer Biomet and helped each of the businesses (Spine and Dental) through significant portfolio optimization actions to support

    4/6/26 4:00:00 PM ET
    $INGN
    Industrial Specialties
    Health Care

    $AAMC
    $ABBV
    $AGX
    $AI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Red Cat Holdings Inc.

    SC 13G/A - Red Cat Holdings, Inc. (0000748268) (Subject)

    12/6/24 4:32:04 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Satellogic Inc.

    SC 13D/A - Satellogic Inc. (0001874315) (Subject)

    11/27/24 4:30:03 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Amendment: SEC Form SC 13D/A filed by Satellogic Inc.

    SC 13D/A - Satellogic Inc. (0001874315) (Subject)

    11/21/24 8:39:01 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology